Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease
- PMID: 35159265
- PMCID: PMC8834599
- DOI: 10.3390/cells11030455
Immunity and Nutrition: The Right Balance in Inflammatory Bowel Disease
Abstract
Inflammatory bowel disease (IBD) is an increasingly urgent medical problem that strongly impairs quality of life for patients. A global rise in incidence has been observed over the last few decades, with the highest incidence rates recorded in North America and Europe. Still, an increased incidence has been reported in the last ten years in newly industrialized countries in Asia, including China and India, both with more than one billion inhabitants. These data underline that IBD is an urgent global health problem. In addition, it is estimated that between 20% and 30% of IBD patients will develop colorectal cancer (CRC) within their lifetime and CRC mortality is approximately 50% amongst IBD patients. Although the exact etiology of IBD is still being defined, it is thought to be due to a complex interaction between many factors, including defects in the innate and adaptive immune system; microbial dysbiosis, i.e., abnormal levels of, or abnormal response to, the gastrointestinal microbiome; a genetic predisposition; and several environmental factors. At present, however, it is not fully understood which of these factors are the initiators of inflammation and which are compounders. The purpose of this review is to analyze the complex balance that exists between these elements to maintain intestinal homeostasis and prevent IBD or limit adverse effects on people's health.
Keywords: cytokines; dysbiosis; immune bowel disease; polyunsaturated fatty acids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.Inflamm Bowel Dis. 2018 Feb 15;24(3):558-572. doi: 10.1093/ibd/izx029. Inflamm Bowel Dis. 2018. PMID: 29462379 Review.
-
The role of cytokine and immune responses in intestinal fibrosis.J Dig Dis. 2020 Jun;21(6):308-314. doi: 10.1111/1751-2980.12879. Epub 2020 Jun 23. J Dig Dis. 2020. PMID: 32410365 Review.
-
Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.United European Gastroenterol J. 2019 Oct;7(8):1008-1032. doi: 10.1177/2050640619867555. Epub 2019 Aug 1. United European Gastroenterol J. 2019. PMID: 31662859 Free PMC article.
-
Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.Front Immunol. 2020 Sep 11;11:2144. doi: 10.3389/fimmu.2020.02144. eCollection 2020. Front Immunol. 2020. PMID: 33042125 Free PMC article. Review.
-
The immune-sleep crosstalk in inflammatory bowel disease.Sleep Med. 2020 Sep;73:38-46. doi: 10.1016/j.sleep.2020.04.020. Epub 2020 Apr 30. Sleep Med. 2020. PMID: 32769031 Review.
Cited by
-
A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China.Sci Rep. 2023 Jul 20;13(1):11700. doi: 10.1038/s41598-023-38396-z. Sci Rep. 2023. PMID: 37474716 Free PMC article.
-
The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms.Nutrients. 2024 Jul 17;16(14):2302. doi: 10.3390/nu16142302. Nutrients. 2024. PMID: 39064745 Free PMC article. Review.
-
The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease.Front Microbiol. 2023 Dec 1;14:1291724. doi: 10.3389/fmicb.2023.1291724. eCollection 2023. Front Microbiol. 2023. PMID: 38107848 Free PMC article. Review.
-
Oral Delivery of Astaxanthin via Carboxymethyl Chitosan-Modified Nanoparticles for Ulcerative Colitis Treatment.Molecules. 2024 Mar 14;29(6):1291. doi: 10.3390/molecules29061291. Molecules. 2024. PMID: 38542929 Free PMC article.
-
Unraveling the causal link: fatty acids and inflammatory bowel disease.Front Immunol. 2024 Jul 25;15:1405790. doi: 10.3389/fimmu.2024.1405790. eCollection 2024. Front Immunol. 2024. PMID: 39119343 Free PMC article.
References
-
- Ng S.C., Shi H.Y., Hamidi N., Underwood F.E., Tang W., Benchimol E.I., Panaccione R., Ghosh S., Wu J.C.Y., Chan F.K.L., et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390:2769–2778. doi: 10.1016/S0140-6736(17)32448-0. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources